The use of serologic tests for the diagnosis of chlamydial infections

Journal of Microbiological Methods

Volumn 42, Issue 3, 2000, Pages 265-279

  Tuuminen, Tamara ^a   Palomäki, Pekka ^a   Paavonen, Jorma ^b  

^a Thermo Fisher Scientific Oy   (Finland)

^b UNIVERSITY OF HELSINKI   (Finland)

Author keywords

Chlamydia pneumoniae; Chlamydia trachomatis; Enzyme immunoassay; Microimmunofluorescence assay; Reliability; Sero epidemiology; Serology

Indexed keywords

BIOASSAY; CHLAMYDIA TRACHOMATIS; CHLAMYDIASIS; CHLAMYDOPHILA PNEUMONIAE; DIAGNOSTIC TEST; ENZYME IMMUNOASSAY; HUMAN; IMMUNOFLUORESCENCE; NONHUMAN; PRIORITY JOURNAL; REVIEW; SEROEPIDEMIOLOGY; SEROLOGY; WESTERN BLOTTING;

EID: 0033810493     PISSN: 01677012     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-7012(00)00209-8     Document Type: Article

References (101)

1. Evaluation of C-reactive protein, an inflammatory marker, and infectious serology as risk factors for coronary artery disease and myocardial infarction
2. Persistence of antibodies to human parvovirus B19 after allogenic bone marrow transplantation: role of prior recipient immunity
3. The natural autoantibody systems: between hypothesis and facts
4. Limits of the immunofluorescence test and advantages of immunoblotting in the diagnosis of chlamydiosis
5. Antigenic variation among strains of Chlamydia pneumoniae
6. Current methods of laboratory diagnostics of Chlamydia trachomatis infection
7. Serological tests for Chlamydia trachomatis infection. Letter to the Editor. Reply
8. A possible association of Chlamydia pneumoniae infectin and acute myocardial infarction in patients younger than 65 years of age
9. Role of serology in the diagnosis of toxoplasmic lymphadenopathy
10. Chlamydia keratokonjunctivitis. Determination of Chlamydia trachomatis specific secretory immunoglobulin A in tears by enzyme immunoassay
11. Serological response to Chlamydia pneumoniae infection
12. Structural and antigenic analysis of Chlamydia pneumoniae
13. Infection with C. pneumoniae in Brooklyn
14. Autoantibodies-diagnostic, pathogenic and prognostic relevance
15. Chronic Chlamydia pneumoniae infection and asthma exacerbation in children
16. Chronic infections and coronary heart disease: is there a link?
17. Significance of specific immunoglobulin M and the chronological diagnosis of 38 cases of toxoplasmic lymphadenopathy
18. Characterization of serum antibody response to Chlamydiae in patients with sexually acquired reactive arthritis
19. An epidemic of infections due to Chlamydia pneumoniae in military conscripts
20. Evaluation of serological methods in the diagnosis of Chlamydia pneumoniae pneumonia during an epidemic in Finland
21. Infection and coronary heart disease
22. Prevalence of antibodies to Chlamydia pneumoniae TWAR in a group of German medical students
23. Identification of Chlamydia pneumoniae-specific protein antigens in immunoblots
24. Evaluation of a new commercial microimmunofluorescence test for detection of antibodies to Chlamydia pneumoniae, Chlamydia trachomatis, and Chlamydia psittaci
25. Diagnostic utility of PCR-enzyme immunoassay, culture, and serology for detection of Chlamydia pneumoniae in symptomatic and asymptomatic patients
26. A new respiratory tract pathogen: Chlamydia pneumoniae strain TWAR
27. Elevated Chlamydia pneumoniae antibodies, cardiovascular events, and azithromycin in male survivors of myocardial infarction
28. Association of Chlamydia pneumoniae (strain TWAR) infection with wheezing, asthmatic bronchitis and adult onset asthma
29. Interlaboratory evaluation of indirect enzyme-linked immunosorbent assay, antibody capture enzyme-linked immunosorbent assay, and immunoblotting for detection of immunoglobulin M antibodies to Toxoplasma gondii
30. Measurement of sputum antibodies in the diagnosis of acute and chronic respiratory infections associated with Chlamydia pneumoniae
31. Relation of Chlamydia pneumoniae antibodies to ischaemic heart disease. Finnish study finds significant association between raised IgG, but not IgA, titers and mortality
32. Prevalence of asymptomatic nasopharyngeal carriage of Chlamydia pneumoniae in subjectively healthy adults: assessment by polymerase chain reaction-enzyme immunoassay and culture
33. Characterization of Chlamydia pneumoniae species-specific proteins immunodominant in humans
34. Rapid detection of Chlamydia pneumoniae by PCR-enzyme immunoassay
35. Antigenic characterization of Chlamydia pneumoniae isolated in Hiroshima
36. Chlamydia pneumoniae and acute myocardial infarction in Jerusalem
37. A seroepidemiologic study of Chlamydia pneumoniae in Rhode Island
38. Identification of a new group of Chlamydia psittaci strains called TWAR
39. Chlamydia pneumoniae (TWAR)
40. Enzyme immunoassay to determine exposure to Chlamydia pneumoniae (strain TWAR)
41. Short-term follow-up by serology of patients given antibiotic treatment for Helicobacter pylori infection
42. Chlamydia pneumoniae and possible relationship to asthma
43. Serological evidence of an association between Chlamydia pneumoniae infection and lung cancer
44. Commentary
45. Cardiovascular disease risk from prior Chlamydia pneumoniae infection can be related to certain antigens recognized in the immunoblot profile
46. Fate of Chlamydia trachomatis in human monocytes and monocyte-derived macrophages
47. Serological cross-reactions between Bartonella and Chlamydia species: implications for diagnosis
48. Clinical consequences of immune responses to Chlamydia in men
49. Outer membrane complex proteins of Chlamydia pneumoniae
50. Past infection by Chlamydia pneumoniae strain TWAR and asymptomatic carotid atheroslerosis
51. Continuous isolation and characterisation of Chlamydia pneumoniae from a patient with diffuse panbronchiolitis
52. Analysis of the human serological response to proteins of Chlamydia trachomatis
53. No serological evidence of association between Chlamydia pneumoniae infection and acute coronary heart disease
54. Serologic response to Bartonella henslae in patients with cat scratch disease and in sick and healthy children
55. Detection of serum antibodies against Chlamydia pneumoniae by ELISA
56. Serological tests for Chlamydia trachomatis infections
57. Detection of antibiotics to Chlamydia trachomatis with peptide-based species-specific enzyme immunoassay
58. An enzyme immunoassay to detect specific antibodies to protein and lipopolysaccharide antigens of Chlamydia trachomatis
59. Enzyme immunoassay with enhanced specificity for detection of antibodies to Chlamydia trachomatis
60. Chlamydia pneumoniae is a risk factor for coronary heart disease in symptom-free elderly men, but Helicobacter pylori and cytomegalovirus are not
61. Monoclonal gammapathies - their identification and biological significance
62. Pelvic inflammatory disease. From diagnosis to prevention. In 'Sexually transmitted diseases'
63. Value of serology as a non-invasive method for evaluating the efficacy of treatment of Helicobacter pylori infection
64. Toxoplasma antigens recognized by naturally occurring human antibodies
65. Serological response to Chlamydia pneumoniae in adults with coronary arterial fatty streaks and fibrolipid plaques
66. Serological response to Chlamydia pneumoniae in patients with sarcoidosis
67. Specific IgE without clinical allergy
68. Prospective study of Chlamydia pneumoniae IgG seropositivity and risks of future myocardial infarction
69. Immunoglobulin M antibodies to hepatitis B core antigen: evaluation of enzyme immunoassay for diagnosis of hepatitis B virus infection
70. Persistence of humoral and cell-mediated immunity to Rubella virus in cloistered nuns and in schoolteachers
71. An epidemic of mild pneumonia due to an unusual strain of Chlamydia psittaci
72. Serological evidence of an association of a novel Chlamydia TWAR, with chronic coronary heart disease and acute myocardial infarction
73. Chronic Chlamydia pneumoniae infection as a risk factor for coronary heart disease in the Helsinki Heart Study
74. Chlamydia pneumoniae and atherosclerosis-an update
75. The significance of Chlamydia specific serum IgA antibodies in Chlamydia trachomatis infections
76. Common infections, idiotypic dysregulation, autoantibody spread and induction of autoimmune diseases
77. Relation of Chlamydia pneumoniae serology to mortality and incidence of ischaemic heart disease over 13 years in the Caerphilly prospective heart disease study
78. An oocyst-transmitted outbreak of toxoplasmosis: patterns of immunoglobulin G and M over one year
79. Relation of Chlamydia pneumoniae antibodies to ischaemic heart disease. Why were samples weakly positive for IgG antibodies not tested for IgA antibodies?
80. Association of prior infection with Chlamydia pneumoniae and angiographically demonstrated coronary artery disease
81. Viljanen, M., 2000. The prevalence of Chlamydia pneumoniae and Mycoplasma pneumoniae IgG and IgA antibodies in a healthy Finnish population as analyzed by quantitative enzyme immunoassays (EIAs)
82. Diagnosis of Chlamydia pneumoniae infection in patients with chronic obstructive pulmonary disease by micro-immunofluorescence and ELISA
83. Evaluation of PCR, culture, and serology for diagnosis of Chlamydia pneumoniae respiratory infections
84. Comparison of Chlamydia pneumoniae isolates by Western blot (immunoblot) analysis and DNA sequencing of the omp 2 gene
85. Immunologic relationship between genital TRIC, lymphogranuloma venereum, and related organisms in a new indirect immunofluorescence test
86. Failure to detect Chlamydia pneumoniae in coronary atheromas of patients undergoing atherectomy
87. Commentary: Chlamydia pneumoniae infection and ischaemic heart disease. The story so far
88. Reactions of polyclonal and neutralizing anti-p54 monoclonal antibodies with an isolated, species-specific 54-kilodalton protein of Chlamydia pneumoniae
89. The species specificity of the microimmunofluorescence antibody test and comparisons with a time resolved fluoroscopic immunoassay for measuring IgG antibodies against Chlamydia pneumoniae
90. On immunological memory